The Pathogenesis Of Colitis In A Novel Th2 Model Of IBD
新型 IBD Th2 模型中结肠炎的发病机制
基本信息
- 批准号:6418028
- 负责人:
- 金额:$ 32.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-05 至 2005-03-31
- 项目状态:已结题
- 来源:
- 关键词:Wiskott Aldrich syndrome antiinfective agents autoimmune disorder cell population study colitis cytokine disease /disorder etiology disease /disorder model gene targeting genetically modified animals helper T lymphocyte inflammatory bowel diseases laboratory mouse mucosal immunity pathologic process
项目摘要
DESCRIPTION (provided by applicant): The overall objective of this project is
to gain further understanding of the mucosal immune system and the defects that
contribute to the pathogenesis of human inflammatory bowel disease (IBD). The
generation of a number of murine models of IBD has facilitated investigation
into the basic mechanisms underlying IBD pathogenesis. Despite the fact that
most murine models of IBD result from a defect in a single protein known to
affect leukocyte function, the specific auto-reactive or regulatory cell
population responsible for disease pathogenesis remains unknown. The
Wiskott-Aldrich syndrome (WAS) is one of several immunodeficiencies that have
been associated with autoimmunity, including IBD. We have recently generated a
mouse model of IBD that results from the targeted disruption of the
Wiskott-Aldrich syndrome protein (WASP). WASP is expressed solely in
hematopoietic cells and is a signaling molecule that regulates cell surface
receptor signals to the cytoskeleton. Abnormalities in this protein lead to the
rare X-linked primary immunodeficiency that carries its name. The majority of
WASP KO (WKO) mice also develop colitis. Our preliminary studies suggest that
the colitis in WKO mice is unique, and perhaps more similar to human IBD than
other murine models of IBD, because WASP-deficiency does not result in the loss
of a specific T-cell class (e.g., alpha-beta T cells) or the absence of one
specific cytokine (e.g., IL-2, IL-10 The development of each hematopoietic
lineage is intact despite the fact that WASP regulates the actin cytoskeleton
in all hematopoietic cells. In contrast with most murine models of IBD that
have a Th1 bias, we demonstrate that lymphocytes isolated from the colonic
lamina propria of WKO mice secrete a Th2 cytokine pattern. In addition, our
genetic and adoptive transfer studies have established the requirement for
lymphocytes in disease pathogenesis and the specific ability of CD4+ T-cells to
transfer disease. Furthermore, WKO mice have a reduction in regulatory T-cells
that are known to regulate autoimmunity in mice. Preliminary data also suggests
that microbes play an essential role in disease pathogenesis. Interestingly,
non-lethal irradiation leads to a dramatic increase in the severity of colitis
with 100 percent disease penetrance. Our first aim is to define the role of
WASP in regulatory and effector T-cell function and the contribution of
additional leukocyte populations in IBD initiation and maintenance. Our second
goal is to define the requirement of Th2 cytokines and the role of inflammatory
and suppressor cytokines in colitis development. Our final goal of this
proposal is to evaluate the role of bacteria and barrier function in colitis
initiation in WKO mice. Overall, this project seeks to take advantage of the
opportunity to study a murine model of colitis with several unique features
that also has a human correlate in order to elucidate the role of cytoskeletal
regulation of leukocytes in mucosal homeostasis.
描述(由申请人提供):该项目的总体目标是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott B Snapper其他文献
Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
抗肿瘤坏死因子α在极早发炎症性肠病中的功效和安全性。
- DOI:
10.1093/ibd/izad196 - 发表时间:
2023 - 期刊:
- 影响因子:4.9
- 作者:
L. Collen;V. Mitsialis;David Y. Kim;Mairead Bresnahan;Jessica Yang;M. Tuthill;A. Combs;J. Barends;M. Field;Enju Liu;R. Bearup;I. Okoroafor;Christoph Klein;A. Muise;A. Bousvaros;J. Ouahed;Scott B Snapper - 通讯作者:
Scott B Snapper
Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort
罕见疾病队列中深度学习模型与临床级变异致病性分类之间的不一致
- DOI:
10.1101/2024.05.22.24307756 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
S. Kong;In;Lauren V Collen;Arjun K Manrai;Scott B Snapper;Kenneth D Mandl - 通讯作者:
Kenneth D Mandl
Scott B Snapper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott B Snapper', 18)}}的其他基金
Employing novel humanized murine strains to develop hematopoietic stem cell gene therapeutic approaches for very early-onset inflammatory bowel disease due to IL10-receptor deficiency.
采用新型人源化小鼠品系开发造血干细胞基因治疗方法,用于治疗因 IL10 受体缺陷所致的极早发炎症性肠病。
- 批准号:
9535567 - 财政年份:2017
- 资助金额:
$ 32.12万 - 项目类别:
Type III interferon Control of Mucosal Immunity
III 型干扰素控制粘膜免疫
- 批准号:
10587625 - 财政年份:2017
- 资助金额:
$ 32.12万 - 项目类别:
Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis
探索小鼠结肠炎模型中的调节性 T 细胞功能障碍
- 批准号:
8232674 - 财政年份:2011
- 资助金额:
$ 32.12万 - 项目类别:
Deciphering the Role of WASP Family Proteins in T Cell Function
解读 WASP 家族蛋白在 T 细胞功能中的作用
- 批准号:
8147996 - 财政年份:2010
- 资助金额:
$ 32.12万 - 项目类别:
Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis
探索小鼠结肠炎模型中的调节性 T 细胞功能障碍
- 批准号:
7877475 - 财政年份:2009
- 资助金额:
$ 32.12万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
6800508 - 财政年份:2003
- 资助金额:
$ 32.12万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
6833455 - 财政年份:2003
- 资助金额:
$ 32.12万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
7161772 - 财政年份:2003
- 资助金额:
$ 32.12万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
6630241 - 财政年份:2003
- 资助金额:
$ 32.12万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
7012813 - 财政年份:2003
- 资助金额:
$ 32.12万 - 项目类别:
相似海外基金
Proteases as targets for new antiinfective agents (A04)
蛋白酶作为新型抗感染药物的靶点(A04)
- 批准号:
200629066 - 财政年份:2011
- 资助金额:
$ 32.12万 - 项目类别:
Collaborative Research Centres
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:
2886084 - 财政年份:1998
- 资助金额:
$ 32.12万 - 项目类别: